share_log

HC Wainwright & Co. Maintains Buy on Pyxis Oncology, Raises Price Target to $7

Moomoo 24/7 ·  Mar 22 06:16

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Pyxis Oncology (NASDAQ:PYXS) with a Buy and raises the price target from $4 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment